[CHRS] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
08-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -87.04%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 475,824 356,071 1,556 1,556 190,106 30,041 31,106 57.49%
PBT 135,707 92,775 -209,409 -238,286 -127,788 -223,938 -87,177 -
Tax 3,463 2,942 4,691 9,440 656 -7,352 -15,413 -
NP 132,244 89,833 -209,339 -238,170 -127,337 -223,260 -87,133 -
Tax Rate -2.55% -3.17% - - - - - -
Total Cost 343,580 266,238 210,895 239,726 317,443 253,301 118,239 19.43%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 27.79 25.23 -13,453.66 -15,306.56 -66.98 -743.18 -280.12 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 1.85 1.29 -3.22 -4.48 -3.04 -6.01 -10.64 -
EPS Diluted 1.62 1.23 -3.22 -4.48 -3.04 -6.01 -10.64 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.